Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2339-2344

  Hajdu, Richard ^a   Thompson, Randall ^a   Sundelof, Jon G ^a   Pelak, Barbara A ^a   Aileen Bouffard, F ^a   Dropinski, James F ^a   Kropp, Helmut ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; HUMAN SERUM ALBUMIN; L 733560; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CHIMPANZEE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; FEMALE; FUNGICIDAL ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RHESUS MONKEY;

EID: 0030711704     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2339     Document Type: Article

References (28)

1. Abruzzo, G., K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin MK-0991 (L-743,872): efficacy in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338.
2. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, D. Krupa, V. B. Pikounis, H. Kropp, and K. Bartizal. 1995. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 39:1077-1081.
3. Balkovec, J. M., R. M. Black, M. L. Hammond, J. V. Heck, R. A. Zambias, G. Abruzzo, K. Bartizal, H. Kropp, C. Trainor, R. E. Schwartz, D. C. McFadden, K. H. Nollstadt, L. A. Pittarelli, M. A. Powles, and D. M. Schmatz. 1992. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP). J. Med. Chem. 35:194-198.
4. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. F. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
5. Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimic crob. Agents Chemother. 39:1070-1076.
6. Bartizal, K., G. Abruzzo, C. Trainor, D. Krupa, K. Nollstadt, D. Schmatz, R. Schwartz, M. Hammond, J. Balkovec, and F. Vanmiddlesworth. 1992. In vitro antifungal activities and in vivo efficacies of 1,3-β-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, L-687,781, a populocandin. Antimicrob. Agents Chemother. 36:1648-1657.
7. Bent, L. Z., and R. L. Galeazzi. 1979. Noncompartmental determination of the steady-state volume of distribution. J. Pharm. Sci. 68:1071-1074.
8. Bouffard, F. A., J. F. Dropinski, J. M. Balkovec, R. M. Black, M. L. Hammond, K. H. Nollstadt, and S. Dreikorn. 1996. L-743,872, a novel antifungal lipopetide: synthesis and structure-activity relationships of new aza-substituted pneumocandins, abstr. F27, p. 104. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Bouffard, F. A., R. A. Zambias, J. F. Dropinski, J. M. Balkovec, M. L. Hammond, G. K. Abruzzo, K. F. Bartizal, J. A. Marrinan, M. B. Kurtz, D. C. McFadden, K. H. Nollstadt, M. A. Powles, and D. M. Schmatz. 1994. Synthesis and antifungal activity of novel cationic pneumocandin Bo derivatives. J. Med. Chem. 37:222-225.
10. Boxenbaum, H. G., S. Riegelman, and R. M. Elashoff. 1974. Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharm. 2:123-148.
11. Brazzell, R. K., Y. H. Park, C. B. Wooldrige, B. McCue, R. Barker, R. Couch, and B. York. 1990. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors. Drug. Metab. Dispos. 18:435-440.
12. Doebbeling, B. N., B. D. Fine, Jr., M. A. Pfaller, C. T. Sheetz, J. B. Stokes, and R. P. Wenzel. 1990. Acute tubular necrosis (ATN) and anion-gap acidosis during therapy with cilofungin (LY-121019) in polyethylene glycol (PEG), abstr. 583, p. 183. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., p. 121. Marcel Dekker, Inc., New York, N.Y.
14. Hajdu, R., R. Thompson, K. White, B. Stark Murphy, and H. Kropp. 1993. Comparative pharmacokinetics of three water-soluble analogues of the lipopetide antifungal compound L-688,786 in mice and rhesus monkeys, abstr. 357, p. 185. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Hajdu, R., J. G. Sundelof, K. Bartizal, G. Abruzzo, C. Trainor, R. Thompson, and H. Kropp. 1991. Comparative pharmacokinetics in four animal species of L-688,786 and its water soluble prodrug, L-693,989, abstr. 209, p. 133. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Kahan, F. M., H. Kropp, J. G. Sundelof, and J. Birnbaum. 1983. Thienamycin: development of imipenem-cilastatin. J. Antimicrob. Chemother. 12 (Suppl. D):1-35.
17. Lee, J. W., P. Kelly, J. Lecciones, D. Coleman, R. Gordee, P. A. Pizzo, and T. J. Walsh. 1990. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits. Antimicrob. Agents Chemother. 34:2240-2245.
18. Powles, M. A., J. Anderson, P. Liberator, and D. M. Schmatz. 1996. Efficacy of semisynthetic pneumocandin analog L-743,872 against Pneumocystis carinii in murine models, abstr. F42, p. 107. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Rouse, M. S., B. M. Tallan, J. M. Steckelberg, N. K. Henry, and W. R. Wilson. 1992. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob. Agents Chemother. 36:56-58.
20. Schmatz, D. M., M. A. Powles, D. C. McFadden, K. Nollstadt, F. A. Bouffard, J. P. Dropinski, P. Liberator, and J. Andersen. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrob. Agents Chemother. 39:1320-1323.
21. Schmatz, D. M., M. A. Powles, D. C. McFadden, L. Pittarelli, J. Balkovec, M. Hammond, R. Zambias, P. Liberator, and J. Anderson. 1992. Antipneumocystis activity of water-soluble lipopetide L-693,989 in rats. Antimicrob. Agents Chemother. 36:1964-1970.
22. Schmatz, D. M., G. Abruzzo, M. A. Powles, D. C. McFadden, J. M. Balkovec, R. M. Black, K. Nollstadt, and K. Bartizal. 1992. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J. Antibiot. 45:1886-1891.
23. Schmatz, D. M., M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3-β-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87:5950-5954.
24. Schwartz, R. E., D. F. Sesin, H. Joshua, K. E. Wilson, A. J. Kempf, K. A. Goklen, D. Kuehner, P. Gailliot, C. Gleason, R. White, E. Inamine, G. Bills, P. Salmon, and L. Zitano. 1992. Pneumocandins from Zalerion arboricola. I. Discovery and isolation. J. Antibiot. 45:1853-1886.
25. Sundelof, J. G., R. Hajdu, W. J. Cleare, J. Onishi, and H. Kropp. 1992. Pharmacokinetics of L-671-329 in rhesus monkeys and DBA/2 mice. Antimicrob. Agents Chemother. 36:607-610.
26. Wagner, J. G. 1993. Pharmacokinetics for the pharmaceutical scientist, p. 84-85. Technomic Publishing Company, Inc., Lancaster, Pa.
27. Walsh, T. J., J. W. Lee, P. Kelly, J. Bacher, J. Lecciones, V. Thomas, C. Lyman, D. Coleman, R. Gordee, and P. A. Pizzo. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-β-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis. Antimicrob. Agents Chemother. 35: 1321-1328.
28. Walsh, T. J., J. W. Lee, E. Roilides, P. Francis, J. Bacher, C. A. Lyman, and P. A. Pizzo. 1992. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases. Clin. Infect. Dis. 14(Suppl. 1):S139-S147.